Molten Ventures PLC GROW

CAMBRIDGE, England, July 29, 2026--Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has raised $20 million in a Series B financing, led by Molten Ventures. Existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension also participated in the round. The new capital will support expansion of the Company’s 3D deep learning imagin

The latest update on Molten Ventures centres on a revised fair value price target, moving from £6.73 to £7.69 in the newest round of modelling. Analysts link this higher central estimate to refreshed assumptions and a more detailed view of how Molten Ventures’ portfolio risk and longer term growth profile are captured in their work, while still flagging both supports and pressure points around the target. Read on to see what is driving the evolving narrative and how to keep track of future...